Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCRECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

News | Drug-Eluting Balloons

September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...

Home September 18, 2017
Home
News | Embolic Protection Devices

September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...

Home September 18, 2017
Home
Technology | SPECT Imaging

September 15, 2017 — Philips highlighted its newest solution for nuclear cardiology, CardioMD IV, at the American ...

Home September 15, 2017
Home
News | Hypertension

September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...

Home September 14, 2017
Home
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.
Feature | Cath Lab

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...

Home September 14, 2017
Home
Videos | Structural Heart Occluders

Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra ...

Home September 13, 2017
Home
News | Peripheral Artery Disease (PAD)

September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...

Home September 13, 2017
Home
News | Peripheral Artery Disease (PAD)

September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...

Home September 13, 2017
Home
News | Cardiac Diagnostics

September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...

Home September 12, 2017
Home
News | Pharmaceuticals

September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...

Home September 12, 2017
Home
News | ESC

September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...

Home September 12, 2017
Home
News | ESC

September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...

Home September 12, 2017
Home
COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease
Feature | Antiplatelet and Anticoagulation Therapies

September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...

Home September 12, 2017
Home
Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.
Feature | Cath Lab

September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as ...

Home September 12, 2017
Home
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | TCT
November 9, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has selected ...
Home November 09, 2017
Home
Subscribe Now